Arrowhead Pharmaceuticals
ARWR
#2768
Rank
NZ$11.06 B
Marketcap
NZ$78.24
Share price
-2.76%
Change (1 day)
10.20%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): NZ-$5.70

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$6.06. In 2025 the company made an earnings per share (EPS) of NZ-$0.01820 an increase over its 2024 EPS that were of NZ-$9.10.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.7031220.39%
2025NZ-$0.01820-99.8%
2024NZ-$9.10161.39%
2023NZ-$3.4817.36%
2022NZ-$2.9719.85%
2021NZ-$2.4861.9%
2020NZ-$1.53-216.67%
2019NZ$1.31-210.77%
2018NZ-$1.1838.3%
2017NZ-$0.86-64.93%
2016NZ-$2.44-16.25%
2015NZ-$2.9128%
2014NZ-$2.28-3.85%
2013NZ-$2.37-31.58%
2012NZ-$3.46331.82%
2011NZ-$0.80-51.11%
2010NZ-$1.64-79.07%
2009NZ-$7.83-37.68%
2008NZ-$12.56-16.87%
2007NZ-$15.1138.33%
2006NZ-$10.92122.22%
2005NZ-$4.9142.11%
2004NZ-$3.46533.33%
2003NZ-$0.55-99.08%
2002NZ-$59.0925%
2001NZ-$47.2733.33%
2000NZ-$35.45-120%
1999NZ$177.27-400%
1998NZ-$59.09-81.48%
1997NZ-$319.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.16-300.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
NZ-$14.54 139.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$4.71-177.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$36.05-694.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
NZ-$3.33-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA